Health Press Release – Weekly Newsletter for March 14-21, 2011Monday, March 21, 2011
Keynote Speakers at eHealth Week 2011 Call for Significant IT Investments in the Health Systems of the Future
Move From Hospital-centric to Community-wide IT Solutions Will Change the Patient Experience of Healthcare; Delegate Registration in Progress
BUDAPEST, Hungary and BRUSSELS, March 14, 2011 – eHealth Week 2011 (ehealthweek.org/), revealed today the list of
keynote speakers who will address delegates at the "eHealth World-Cup", which
is to be held in Budapest, Hungary on 10-12 May, 2011. …. Original source : Keynote Speakers at eHealth Week 2011 Call for Significant IT Investments in the Health Systems of the Future.
Deal Would Provide European Expansion and Portfolio Diversification For Elanco, Lilly's Animal Health Division
INDIANAPOLIS, March 14, 2011 – Elanco, the animal health division of Eli Lilly and Company (NYSE: LLY),
today announced that Lilly has made an irrevocable, unconditional offer to
acquire the animal health business of Janssen Pharmaceutica NV, a Johnson &
Johnson Company. The two … Read the original article on Gaea Times at : Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health.
Academic and Government Institutes Throughout Spain Gain Access to Abstracts and Citations Data
AMSTERDAM, March 14, 2011 – Elsevier's SciVerse Scopus (www.info.sciverse.com/scopus/)
database was selected by the Spanish Foundation for Science and Technology
(FECYT), a public foundation that supports the Spanish Ministry of Science
and Innovation (MICINN), to assist academic and government institutes
throughout Spain in the tracking and …. Original source : Spanish Foundation for Science and Technology Selects Elsevier's SciVerse Scopus Database.
Health Robotics Continues Worldwide Distribution Channel Expansion With Gamida MedEquip Ltd. in Israel
BOZEN, Sud-Tirol, Italy, March 14, 2011 – Health Robotics today announced that it recently signed an exclusive
distribution agreement for its CytoCare, i.v.STATION, and i.v.SOFT
world-leading technologies with Israel-based medical technology leader Gamida
MedEquip Ltd. This partnership represents Health Robotics' market entry into
its 17th new country over the past 20 months, persisting on its worldwide
quest to pervasively … Read more : Health Robotics Continues Worldwide Distribution Channel Expansion With Gamida MedEquip Ltd. in Israel.
Ingenuity Announces RNA-Sequencing Workflow Support and First-of-Its-Kind microRNA Filtering Capability With Latest Release of IPA
REDWOOD CITY, California, March 15, 2011 – Ingenuity(R) Systems, a leading provider of information and analytics
solutions for life science researchers, today announced new features to
support RNA-Sequencing workflows and microRNA research in IPA(R). Processed
RNA-Seq datasets can now be uploaded directly into IPA and analyzed in the
context of pathways and diseases for a rich biological interpretation …. Original source : Ingenuity Announces RNA-Sequencing Workflow Support and First-of-Its-Kind microRNA Filtering Capability With Latest Release of IPA.
Finesse Solutions Showcases SmartBag with Fully Integrated Single-Use pH and pO2 Sensors for Rocker Bioreactors at Interphex 2011
SAN JOSE, California, March 15, 2011 – Finesse Solutions, LLC, a manufacturer of measurement and
control solutions for life sciences process applications, announced a live
demonstration of its new SmartBag product for rocker bioreactors at Interphex
2011 in New York, March 29-31.
Bioprocessing specialists will get a close-up look at the
first robust single-use of …. Source : Gaea News Network.
Circle Surrogacy to Host London Seminar on Surrogacy in the United States for Local Couples and Singles
Event marks the agency's return to Britain, and its third European visit in 2011
LONDON, March 15, 2011 – Circle Surrogacy, one of the oldest surrogate parenting agencies in the
United States, announces an informational seminar to be held on March 26,
2011 in London. The meeting will give prospective parents an opportunity to
hear expert advice about …. Read the original article : Circle Surrogacy to Host London Seminar on Surrogacy in the United States for Local Couples and Singles.
Nottingham University Hospital is First U.K. User of Elekta’s Electronic Medical Record Workspace for Image Guided Radiation Therapy
From single workstation, U.K. center coordinates advanced IGRT therapy for patients with cancer
NOTTINGHAM, England, March 15, 2011 – Delivering Image Guided Radiation Therapy (IGRT) effectively and safely
involves careful coordination of sophisticated systems, such as the therapy
machine and its imaging subsystems, as well as the electronic medical record
(EMR) used to schedule and record patient treatments. … Read : Nottingham University Hospital is First U.K. User of Elekta's Electronic Medical Record Workspace for Image Guided Radiation Therapy.
Evaluation of Alternative Treatment Strategies Incorporating Platelet Function Testing Recommended
SAN DIEGO, March 15, 2011 – Accumetrics, Inc., developer of the VerifyNow(R) System, the first rapid
and easy-to-use point-of-care system for measuring platelet reactivity to
multiple antiplatelet agents, announced today that the primary results of the
GRAVITAS trial have been published in The Journal of the American Medical
… Read the original article on Gaea Times at : Accumetrics Announces Publication of GRAVITAS Primary Results in JAMA.
HOLLYWOOD, California, March 15, 2011 – XTIO2 INC. (www.xti.tm/)(XTI) presented the 83rd Academy(R)
Award-nominees with the XTI ANTI-GERM / ANTI-VOC / ANTI-ALLERGY SYSTEM,
consisting of XTI 360(TM) Nanocoating
and XTI(TM) Nano-Facemask (www.cnbc.com/id/41788655 ). It is the
world's most effective preventive measure and the best defense against germs
transmitted via air and contact surfaces. The unique nanocoating protects
people from germs … Read this article on Gaea Times at : OSCAR(R) Nominees Receive (XTIO2 INC.) XTI 360(TM) NANO Coating ANTI-GERM SYSTEM.
ANN ARBOR, Michigan and LONDON, March 16, 2011 – NextGen Group plc (AIM:NGG) is pleased to announce that its
subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement
and qualification, has launched its first multiple protein (multiplex) assay,
plasmadiscovery41, for oncology biomarker discovery and qualification. The
assay simultaneously measures 41 human plasma proteins that are thought to
have … Read more : NextGen Sciences Launches Multiple Protein Plasma Oncology Biomarker Assay.
MADRID and OEIRAS, Portugal, March 16, 2011 – Digna Biotech and Biotecnol (The Consortium) announced today that the
Spanish Regulatory Medicine Agency has authorized the start of a Phase I
Clinical Trial in healthy volunteers for Cardiotrophin-I (CT-I). The study
will be conducted in Hospital Universitario Puerta de Hierro de Majadahonda
in Madrid and Cl??nica Universidad de Navarra …. Source : Cardiotrophin I to Start Phase I Clinical Studies.
The Additional Funds Will Enable the Company to Expand its Therapeutic Research Activities
STRASBOURG, France, March 16, 2011 – Polyplus-transfection SA, which specializes in the development
of innovative solutions for the delivery of nucleic acids in research and
therapeutics, announces the completion of a funding round in which it raised
EUR 2.5 million. This new round brings in …. Original source : Polyplus-Transfection Raises EUR 2.5 Million in Latest Funding Round.
Finesse Solutions Introduces New T700 cGMP Upstream Processing Platform Featuring G3 Hardware and Fully Integrated Single-Use Sensors
SAN JOSE, California, March 16, 2011 – Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and
control solutions for life sciences process applications, announced the
release of the T700(TM) upstream processing platform for single-use
bioreactors ranging from 25L to 2,000L in size. The T700 family of turn-key
control systems is designed to the highest performance and … Read more »».
Dutch Firm Launches World’s First Diagnostic Chip That Combines DNA Technologies to Rapidly Classify AML Patients
ROTTERDAM, The Netherlands, March 16, 2011 – Each year over eight million people die of cancer worldwide. Patients'
chances of survival vary widely: depending on the type of cancer involved,
the stage at which it is diagnosed and the speed with which appropriate
treatment is launched. Skyline Diagnostics B.V., a Dutch firm associated with
the Erasmus Medical Center …. Original article : Dutch Firm Launches World's First Diagnostic Chip That Combines DNA Technologies to Rapidly Classify AML Patients.
HAMBURG, Germany, March 17, 2011 – Around 5-10% of adults in Central and Western Europe suffer
from kidney and ureteral stone disease. These solid formations occur when
substances that normally dissolve in the urine are separated out and
deposited as fine crystals in those organs. Such stones can be found in the
renal calyces, renal pelvis and lower … Read more : Gently Does it – Safe and Gentle Stone Retrieval.
WASHINGTON, LONDON and HONG KONG, March 17, 2011 – SuperNova Diagnostics(R), Inc., a privately-held global diagnostics
company for human and non-human health applications, announced today that it
has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology Co., Ltd.
("KSB"), a biotechnology diagnostics company specializing in research,
manufacture and distribution of in-vitro diagnostic kits and research
reagents in China …. Read the original article : SuperNova Diagnostics(R) Announces Agreement with KSB Diagnostics of China.
LONDON, March 18, 2011 – Alliance Medical Group, Europe's leading independent diagnostic imaging
service provider, has today announced the appointment of Guy Blomfield as
Group Chief Operating Officer. He joins Alliance Medical from General
Healthcare Group (GHG).
Guy's appointment follows the successful restructuring of Alliance
Medical Group in 2010, which has provided the company with … Original article on : Alliance Medical Group Announces new Chief Operating Officer.
Amgen Statement on CHMP Opinion on Vectibix(R) (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer
THOUSAND OAKS, California, March 18, 2011 – Amgen (Nasdaq: AMGN) today issued the following statement:
Amgen has received notice that the Committee for Medicinal Products for
Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a
negative opinion for Amgen's application to extend the marketing
authorization in Europe for Vectibix(R) (panitumumab) to …. Source article on Gaea Times at : Amgen Statement on CHMP Opinion on Vectibix(R) (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer.
HNA Group's Airplane named "Brightness Action" will take the medical team to Africa for 500 cataract surgeries planned during 9 days
BEIJING, March 18, 2011 – The launching ceremony for the "2011 China-Africa Brightness
Action" was held at the Beijing HNA Marriott Hotel on March 17th.
Co-organized by the National Committee of Blindness Prevention (NCBP), China
Association for … Read the original article on Gaea Times at : '2011 China-Africa Brightness Action' Launched in Beijing.